Home›Stock Screener›Epigral›Quarterly Results

Epigral Quarterly Results

Latest Quarter Net Profit
₹51 Cr
QSept 2025
Quarterly Results

Epigral quarterly results. In Sept 2025, Epigral (EPIGRAL) reported revenue ₹589 Cr and net profit ₹51 Cr — revenue -6.8% YoY. Review Epigral P/E valuation to evaluate earnings-based valuation against sector peers.

EPIGRAL Quarterly Results — Revenue, Profit & EPS Highlights

Epigral latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Check EPIGRAL company valuation to track the company's total market size over time.

  • Revenue of ₹589 Cr in Sept 2025 (-6.7% vs Mar 2025, -6.8% vs Sept 2024)
  • Net Profit of ₹51 Cr in Sept 2025 (-41.4% vs Mar 2025, -37.0% vs Sept 2024)
  • EBITDA of ₹134 Cr in Sept 2025 (-24.3% vs Mar 2025)
  • Operating Margin of 22.0% in Sept 2025 (-6.0pp vs Mar 2025)
  • Earnings Per Share of ₹11.87 in Sept 2025 (-41.1% vs Mar 2025)

Epigral Quarterly Results — Revenue, EBITDA, Net Profit & EPS

EPIGRAL quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 589 631 615 603 632 -6.7% -6.8%
Net Profit (₹ Cr) 51 87 161 39 81 - -
EBITDA (₹ Cr) 134 177 172 108 185 - -
EPS (₹) 11.87 20.14 37.25 9.07 19.57 - -
Operating Margin (%) 22.0% 28.0% 27.0% 17.0% 29.0% - -

EPIGRAL Share Price Trend — 1-Year Movement Across Quarterly Results

Epigral 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit EPIGRAL screener.

Profitability Ratios

Profit Margin 8.7%
EBITDA Margin 22.8%
Operating Margin 22.0%
ROE (Annual) 10.7%

Balance Sheet Highlights

Total Assets ₹3,152 Cr
Total Equity ₹1,905 Cr
Current Assets ₹775 Cr
Current Liabilities ₹755 Cr

Cash Flow Analysis

Operating Cash Flow ₹398 Cr
Investing Cash Flow ₹-401 Cr
Financing Cash Flow ₹-8 Cr
Net Cash Flow ₹-11 Cr

Current Market Data

Current Price ₹1017.30
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Dec 2025 603
Jun 2025 615
Mar 2025 631
Sept 2025 589

Net Profit Trend (₹ Cr)

Dec 2025 39
Jun 2025 161
Mar 2025 87
Sept 2025 51

Operating Margin Trend (%)

Dec 2025 17.0%
Jun 2025 27.0%
Mar 2025 28.0%
Sept 2025 22.0%

EPIGRAL vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap

Epigral latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Pidilite Industries
Mar 2026 		₹149,017.59 Cr 1487.7 3,648 584 -21.7% - 16.0% 261.5
SRF
Mar 2026 		₹73,697.14 Cr 2460.0 4,557 582 -8.4% - 12.8% 125.3
Linde
Mar 2026 		₹53,281.32 Cr 6041.0 621 77 -11.5% - 12.4% 665.3
Coromandel Internat…
Mar 2026 		₹52,036.94 Cr 1801.4 6,068 115 -26.1% - 1.9% 379.2
Gujarat Fluorochemi…
Mar 2026 		₹50,280.54 Cr 4429.8 1,375 100 -14.1% - 7.3% 446.6
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores